Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-08T04:54:11.995Z Has data issue: false hasContentIssue false

Variability of MDRO Reporting Across Tennessee Microbiology Laboratories

Published online by Cambridge University Press:  16 September 2024

Matthew Lokant
Affiliation:
Vanderbilt University Medical Center
Christopher Wilson
Affiliation:
Tennessee Department of Health
Tom Talbot
Affiliation:
Vanderbilt University School of Medicine
Priscilla Pineda
Affiliation:
Tennessee Department of Health
Erin Hitchingham
Affiliation:
Tennessee Department of Health
Melphine Harriott
Affiliation:
TN Department of Health HAI/AR Program
Raquel Villegas
Affiliation:
state of TN
Kaleb Wolfe
Affiliation:
Vanderbilt University Medical Center
Milner Owens Staub
Affiliation:
Vanderbilt University Medical Center

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Identification and timely reporting of multi-drug resistant organisms (MDROs) drives efficacy of infection prevention efforts. Data on MDRO reporting timeliness and inter-facility variability are limited. Facility-dependent variability in MDRO reporting across Tennessee was examined to identify opportunities for MDRO surveillance improvement. Methods: Data for reported Tennessee MDROs including carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Candida auris, were obtained from the southeast regional Antibiotic Resistance Laboratory Network (ARLN) from 2018-2022, excluding screening and colonization specimens. Variance in days accrued from specimen collection to ARLN receipt was analyzed using one-way analysis of variance (ANOVA) with Tukey’s test (SAS 9.4). Facilities were categorized as fast (1-10 days), slow (11-20 days), or delayed (21-100 days) reporters. Results: There were 9,569 MDRO isolates reported. CRPA was reported faster than other MDROs (p < 0.001), while specimens from West Tennessee compared to other regions (p < 0.001) (Figure) and blood cultures compared to other specimens were reported more slowly (p < 0.001) (Table). There was no difference in reporting times for facilities using on-site microbiology laboratories versus reference laboratories (P = 0.062). Conclusion: MDRO reporting times varied across Tennessee by region, specimen, and organism. Future work to elucidate drivers of variability will consist of surveys and focused interviews with laboratory personnel to identify shared and unique barriers and opportunities for improvement.

Type
Surveillance
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America